Johnson & Johnson
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
JNJ News
For Immediate Release Chicago, IL – April 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might aff...
A panel of jurors in Chicago ordered Johnson & Johnson (NYSE:JNJ) and its consumer care spinoff Kenvue (NYSE:KVUE) to pay $45M to the family of an Illinois resi...
Analyst ratings
57%
of 23 ratingsMore JNJ News
One of the biggest problems for Johnson & Johnson (NYSE:JNJ) in the last decade or so has been talc. This powder, which many swore by until a potential link bet...
A jury in Florida found that Johnson & Johnson's (NYSE:JNJ) talc-based baby powder did not cause cancer in a woman in the latest trial to proceed after the comp...
Loading... Loading... The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson...
(Adds detail on separate WHO alert on ingredient contamination, paragraphs 14-17) By Jennifer Rigby LONDON, April 19 (Reuters) - The World Health Organization...
The board of Johnson & Johnson ( ) has announced that it will be increasing its dividend by 4.2% on the 4th of June to $1.24, up from last year's comparable pay...
This week's dividend activity included increased payouts from Johnson & Johnson (NYSE:JNJ) and KB Home (KBH) as well as declarations from companies like Qualcom...
For Immediate Release Chicago, IL – April 19, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...